Saturday, May 30, 2026
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Sport
  • Science and Tech
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • My Space
    • Education Today
    • Reviews
    • Property
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • My Space
  • Reviews
  • Education Today
  • Property
  • Lifestyle
Home | News | Cervical Cancer Vaccine Must Be Made Part Of Immunisation Program Harish Rao

Cervical Cancer vaccine must be made part of immunisation program: Harish Rao

Along with Serum Institute (AS), the DBT on Thursday announced the launch of the indigenously made cervical cancer vaccine.

By Telangana Today
Updated On - 1 September 2022, 06:33 PM
Cervical Cancer vaccine must be made part of immunisation program: Harish Rao
File Photo
whatsapp facebook twitter telegram

Hyderabad: Health Minister, T Harish Rao on Thursday, while congratulating Department of Biotechnology (DBT) under union Ministry of Science Technology and Serum Institute for developing a vaccine for cervical cancer, hoped that it is made part of National Immunisation Program and becomes available available for free of cost for girls aged between 9 years and 14 years.

“Congratulations to Serum Institute and Department of Biotechnology for launching indigenously developed Quadrivalent Human Papillomavirus vaccine against cervical cancer. Hope it will be a part of the National immunisation program for 9-14year old girls and reach the real beneficiaries,” Health Minister on social media platform Twitter, said.

Also Read

  • India’s first vaccine against cervical cancer to come on September 1
  • Don’t ignore these 10 warning signs of Cervical Cancer
  • Cervical cancer most common after breast cancer in women: AIIMS

Along with Serum Institute (AS), the DBT on Thursday announced the launch of the indigenously made cervical cancer vaccine. According to Serum Institute CEO, Adar Poonawalla, the cervical cancer vaccine will be first made available in India and later to the other countries. The vaccine is expected to be priced anywhere between Rs. 200 and Rs. 400 and the Serum Institute is preparing to manufacture 200 million doses in the next two years.

 

  • Follow Us :
  • Tags
  • Cervical Cancer vaccine
  • Department of Biotechnology
  • Serum Institute

Related News

  • One Day One Genome initiative to harness the microbial potential of India

    One Day One Genome initiative to harness the microbial potential of India

  • Editorial: Harnessing power of biotech

    Editorial: Harnessing power of biotech

  • India working on developing vaccine for dengue

    India working on developing vaccine for dengue

  • Serum Institute developing vaccine to protect against JN.1 variant, says former ICMR DG

    Serum Institute developing vaccine to protect against JN.1 variant, says former ICMR DG

Latest News

  • Income meter has stopped: Rahul Gandhi slams Modi govt after meeting auto drivers

    5 mins ago
  • India wins 10 medals with perfect podium finish at U17 Asian Wrestling Championships 2026

    12 mins ago
  • Telangana BJP chief accuses Congress govt of negligence in paddy purchase

    17 mins ago
  • State Sports Associations seek release of pending funds in Telangana

    22 mins ago
  • Abhishek attack reflects BJP Vendetta politics: Congress

    24 mins ago
  • Vikings PC clinch CCPL Club League title with dominant final win

    25 mins ago
  • Satwik and Chirag stun world champions to enter Singapore Open final

    28 mins ago
  • TGSRTC withdraws summer discount, regular bus fares back from June 1

    29 mins ago

company

  • Home
  • About Us
  • Contact Us
  • Privacy Policy

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

  • Telangana Today Telangana Today
Telangana Today Telangana Today

© Copyrights 2024 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam